19.10.2023 03:50:00

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMTI, ICPT, FNCB

NEW YORK, Oct. 18, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC (PRNewsfoto/Halper Sadeh LLP)

Applied Molecular Transport Inc. (NASDAQ: AMTI)'s sale to Cyclo Therapeutics, Inc. for 0.174 shares of Cyclo for each share of Applied Molecular. If you are an Applied Molecular shareholder, click here to learn more about your rights and options.

Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT)'s sale to Alfasigma S.p.A. for $19.00 per share in cash. If you are an Intercept shareholder, click here to learn more about your rights and options.  

FNCB Bancorp, Inc. (NASDAQ: FNCB)'s sale to Peoples Financial Services Corp. for 0.1460 shares of Peoples common stock for each share of FNCB common stock. If you are a FNCB shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-amti-icpt-fncb-301961410.html

SOURCE Halper Sadeh LLP

Nachrichten zu Intercept Pharmaceuticals Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Intercept Pharmaceuticals Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!